Unlike what it has been described for lung, pancreatic and endometrial cancer cells (6,10,11), ABTL0812 does not reduce phosphorylation of AKT or mTORC1 substrates, despite inducing the upregulation of TRIB3 and LC3-II levels. The gene discussed is AKT1; the disease is endometrial cancer.